- Report
- February 2024
- 255 Pages
Global
From €4235EUR$4,455USD£3,558GBP
€4706EUR$4,950USD£3,953GBP
- Report
- December 2022
- 260 Pages
Global
From €2282EUR$2,400USD£1,917GBP
- Report
- May 2023
- 244 Pages
Global
From €2614EUR$2,750USD£2,196GBP
€5229EUR$5,500USD£4,393GBP
- Report
- May 2022
- 263 Pages
Global
From €2495EUR$2,625USD£2,096GBP
€4991EUR$5,250USD£4,193GBP
- Report
- June 2023
- 186 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- March 2021
- 216 Pages
Global
From €1307EUR$1,375USD£1,098GBP
€2614EUR$2,750USD£2,196GBP
- Report
- May 2019
- 140 Pages
Global
From €1307EUR$1,375USD£1,098GBP
€2614EUR$2,750USD£2,196GBP
- Report
- January 2024
- 150 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- October 2023
- 195 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- November 2022
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- October 2023
- 89 Pages
Canada
From €3327EUR$3,500USD£2,795GBP
- Report
- June 2023
- 112 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- February 2024
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- April 2023
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2022
- 90 Pages
Europe
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2022
- 115 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- March 2024
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- November 2023
- 76 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- July 2021
- 120 Pages
Global
From €3898EUR$4,100USD£3,274GBP
- Report
- October 2019
- 241 Pages
Global
From €4230EUR$4,450USD£3,554GBP

Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, such as cancer. Cancer markers are a type of biomarker that can be used to detect the presence of cancer in a patient. They can be used to diagnose, monitor, and predict the progression of cancer. Cancer markers can be proteins, hormones, enzymes, or other molecules that are produced by cancer cells or are associated with the presence of cancer.
Cancer markers are used in a variety of ways, including to detect the presence of cancer, to monitor the progression of the disease, and to predict the response to treatment. They can also be used to identify patients who are at risk for developing cancer.
The cancer marker market is a rapidly growing segment of the biomarker market. It is driven by the increasing prevalence of cancer, the development of new technologies for detecting and monitoring cancer, and the increasing demand for personalized medicine.
Companies in the cancer marker market include Abbott Laboratories, Agilent Technologies, Becton Dickinson, Bio-Rad Laboratories, Cepheid, and Roche Diagnostics. Show Less Read more